Mutations in genes such as BRCA1 and BRCA2 account for 10%–15% of heritable breast cancer cases, while other high-risk genes, including TP53, CDH1, phosphate and tensin homolog (PTEN), and STK11, also lead to breast cancer development. This evidence concerns the gene BRCA2 and breast carcinoma.